Literature DB >> 20592298

Triptan therapy in migraine.

Elizabeth Loder1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20592298     DOI: 10.1056/NEJMct0910887

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  49 in total

Review 1.  Chemical mediators of migraine: preclinical and clinical observations.

Authors:  Saurabh Gupta; Stephanie J Nahas; B Lee Peterlin
Journal:  Headache       Date:  2011-06       Impact factor: 5.887

Review 2.  A Critical Evaluation on MOH Current Treatments.

Authors:  Andrea Negro; Martina Curto; Luana Lionetto; Simona Guerzoni; Luigi Alberto Pini; Paolo Martelletti
Journal:  Curr Treat Options Neurol       Date:  2017-08-15       Impact factor: 3.598

Review 3.  Calcitonin gene-related peptide (CGRP): a new target for migraine.

Authors:  Andrew F Russo
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-08       Impact factor: 13.820

Review 4.  Sumatriptan-associated ischemic colitis: case report and review of the literature and FAERS.

Authors:  Thuc Quyen Nguyen; James H Lewis
Journal:  Drug Saf       Date:  2014-02       Impact factor: 5.606

Review 5.  Needle-free subcutaneous sumatriptan: in the acute treatment of migraine attacks or cluster headache episodes.

Authors:  James E Frampton
Journal:  CNS Drugs       Date:  2011-11-01       Impact factor: 5.749

Review 6.  Rizatriptan-Induced Colonic Ischemia: A Case Report and Literature Review.

Authors:  Thomas D Dieringer; David M Crossland; Thomas C Mahl
Journal:  Am J Gastroenterol       Date:  2018-01       Impact factor: 10.864

Review 7.  CGRP and migraine: could PACAP play a role too?

Authors:  Eric A Kaiser; Andrew F Russo
Journal:  Neuropeptides       Date:  2013-10-23       Impact factor: 3.286

8.  The effect of migraine and tension-type headaches on female sexual functions: A prospective, cross-sectional, controlled study.

Authors:  Mustafa Aydın; Alper Bitkin; Lokman İrkılata; Ahmet Yılmaz; Caner Moral; Mustafa Kemal Atilla
Journal:  Turk J Urol       Date:  2018-09-01

Review 9.  Frovatriptan: a review of its use in the acute treatment of migraine.

Authors:  Mark Sanford
Journal:  CNS Drugs       Date:  2012-09-01       Impact factor: 5.749

10.  A review of the use of frovatriptan in the treatment of menstrually related migraine.

Authors:  Gianni Allais; Chiara Benedetto
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.